InsidersTradesSigma
Orchard Therapeutics plc: insider trades · United States · SEC (Form 4)
SEC:orchard-therapeutics-plc-a94336US·SEC (Form 4)Mcap 12M€Financial Services
Discover the full insider trade history of Orchard Therapeutics plc, a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Financial Services sector, Orchard Therapeutics plc has recorded 2 insider filings. Market capitalisation: €11.5m. The latest transaction was reported on 5 April 2022 (Acquisition). Among the most active insiders: Gaspar Bobby. Every trade is openly available.
2
Insider Decl.
0
Thresholds
€16,762
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended July 2024 · cache
54.00 €
Analyst consensus
Income statement
Revenue9.6 M€
Gross profit5.4 M€56% margin
Net income1.6 M€34.8% margin
Valuation
PER (trailing)3.9x
P/Book53.5x
Beta-0.18
Balance sheet & cash
Market cap11.5 M€
Total debt40.2 M€
Free Cash Flow−6.1 M€
Debt / Equity153%
Profitability & ownership
ROE14.9%
ROA4.4%
% insiders67.6%
% institutions10.1%
Last declaration on 5 April 2022
Declarations2 total
Executives▲Purchase◆Signal · 54SEC
€10,01115,000 shares@ €0.66740.087% mcap100.0% of flow
Ordinary Shares
SEC:0001209191-22-022988:0·
Ideal exit: 27 Dec 2022 (T+270)
Executives▲Purchase33SEC
€6,75010,000 shares@ €0.6750.059% mcap100.0% of flow
Ordinary Shares
SEC:0001209191-22-022336:0·
Ideal exit: 27 Dec 2022 (T+270)
2 of 2 declarations